Form 8-K - Current report:
SEC Accession No. 0000917520-23-000007
Filing Date
2023-01-25
Accepted
2023-01-25 16:30:25
Documents
13
Period of Report
2023-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K iart-20230125.htm   iXBRL 8-K 31384
  Complete submission text file 0000917520-23-000007.txt   195151

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20230125.xsd EX-101.SCH 2225
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20230125_def.xml EX-101.DEF 14477
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20230125_lab.xml EX-101.LAB 28047
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20230125_pre.xml EX-101.PRE 14984
7 EXTRACTED XBRL INSTANCE DOCUMENT iart-20230125_htm.xml XML 10588
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 23552797
SIC: 3841 Surgical & Medical Instruments & Apparatus